Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDUnited Therapeutics Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 8 | $5.72 | $5.76 | $5.74 |
| Q2 2024 | 8 | $6.50 | $6.52 | $6.51 |
| Q3 2024 | 4 | $6.52 | $6.53 | $6.52 |
| Q4 2024 | 11 | $5.24 | $8.09 | $6.59 |
| Q1 2025 | 4 | $7.17 | $7.35 | $7.27 |
| Q2 2025 | 2 | $7.51 | $8.39 | $7.94 |
| Q3 2025 | 2 | $7.84 | $8.75 | $8.28 |
| Q4 2025 | 2 | $7.39 | $8.25 | $7.81 |
United Therapeutics Corporation Earnings Date And Information
United Therapeutics Corporation last posted its earnings results on Wednesday, October 30th, 2024. The company reported $6.39 earnings per share for the quarter, missing analysts' consensus estimates of $6.43 by $0.04. The company had revenue of 748.90 M for the quarter and had revenue of 2.33 B for the year. United Therapeutics Corporation has generated $21 earnings per share over the last year ($19.81 diluted earnings per share) and currently has a price-to-earnings ratio of 14.65. United Therapeutics Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
United Therapeutics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2024 | Q3 2024 | $6.43 | $6.93 | 0.5 | $722.62 M | $748.90 M |
| 07/31/2024 | Q2 2024 | $6.40 | $6.26 | -0.14 | $691.87 M | $714.90 M |
| 05/01/2024 | Q1 2024 | $5.65 | $6.52 | 0.87 | $677.70 M | |
| 02/21/2024 | Q4 2023 | $4.19 | $4.62 | 0.43 | $614.70 M | |
| 11/01/2023 | Q3 2023 | $5.04 | $5.71 | 0.67 | $585.82 M | $609.40 M |
| 08/02/2023 | Q2 2023 | $4.51 | $5.53 | 1.02 | $524.18 M | $596.50 M |
| 05/03/2023 | Q1 2023 | $4.52 | $5.20 | 0.68 | $506.90 M | |
| 02/22/2023 | Q4 2022 | $4.51 | $2.88 | -1.63 | $491.50 M | |
| 11/02/2022 | Q3 2022 | $3.89 | $4.91 | 1.02 | $493.21 M | $516.00 M |
| 08/03/2022 | Q2 2022 | $4.13 | $2.41 | -1.72 | $461.06 M | $466.90 M |
| 05/04/2022 | Q1 2022 | $3.35 | $5.03 | 1.68 | $461.90 M | |
| 02/24/2022 | Q4 2021 | $3.72 | $2.49 | -1.23 | $415.20 M | |
| 11/03/2021 | Q3 2021 | $3.59 | $3.62 | 0.03 | $421.45 M | $444.70 M |
| 08/04/2021 | Q2 2021 | $3.02 | $3.85 | 0.83 | $378.56 M | $446.50 M |
| 05/05/2021 | Q1 2021 | $2.94 | $0.63 | -2.31 | $379.10 M | |
| 02/24/2021 | Q4 2020 | $3.14 | $2.22 | -0.92 | $384.90 M | |
| 10/28/2020 | Q3 2020 | $2.83 | $3.86 | 1.03 | $358.46 M | $380.10 M |
| 07/29/2020 | Q2 2020 | $2.87 | $2.43 | -0.44 | $339.98 M | $362.00 M |
| 04/29/2020 | Q1 2020 | $2.75 | $3.14 | 0.39 | $356.30 M | |
| 02/26/2020 | Q4 2019 | $2.68 | $1.20 | -1.48 | $311.10 M |
United Therapeutics Corporation Earnings: FAQ's
When is United Therapeutics Corporation's earnings date?
United Therapeutics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
How can I listen to United Therapeutics Corporation's earnings conference
call?
The conference call for United Therapeutics Corporation's latest earnings report can be listened to online.
How can I read United Therapeutics Corporation's conference call transcript?
The conference call transcript for United Therapeutics Corporation's latest earnings report can be read online.
How much revenue does United Therapeutics Corporation generate each year?
United Therapeutics Corporation (:UTHR) has a recorded annual revenue of $2.33 B.
How much profit does United Therapeutics Corporation generate each year?
United Therapeutics Corporation (:UTHR) has a recorded net income of $2.33 B. United Therapeutics Corporation has generated $21.04 earnings per share over the last four quarters.
What is United Therapeutics Corporation's price-to-earnings ratio?
United Therapeutics Corporation (:UTHR) has a price-to-earnings ratio of 14.65 and price/earnings-to-growth ratio is 2.77.